|
ELK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.643200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.421420E-01 |
| Normal-vs-Stage2 |
8.454400E-01 |
| Normal-vs-Stage3 |
1.249620E-02 |
| Normal-vs-Stage4 |
4.084400E-01 |
| Stage1-vs-Stage2 |
3.372800E-01 |
| Stage1-vs-Stage3 |
2.988200E-04 |
| Stage1-vs-Stage4 |
8.360300E-02 |
| Stage2-vs-Stage3 |
5.888400E-02 |
| Stage2-vs-Stage4 |
4.748400E-01 |
| Stage3-vs-Stage4 |
6.368600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.245800E-01 |
| Normal-vs-AfricanAmerican |
9.748200E-01 |
| Normal-vs-Asian |
7.703000E-01 |
| Caucasian-vs-AfricanAmerican |
9.194400E-01 |
| Caucasian-vs-Asian |
8.110200E-01 |
| AfricanAmerican-vs-Asian |
7.647000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.965430E-01 |
| Normal-vs-Female |
3.263400E-03 |
| Male-vs-Female |
1.60148999999166E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.959600E-01 |
| Normal-vs-Extreme_Weight |
4.168600E-01 |
| Normal-vs-Obese |
1.881750E-01 |
| Normal-vs-Extreme_Obese |
7.317500E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.316400E-01 |
| Normal_Weight-vs-Obese |
4.819000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.466000E-02 |
| Extreme_Weight-vs-Obese |
5.991700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.850200E-01 |
| Obese-vs-Extreme_Obese |
1.325730E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.959800E-02 |
| Normal-vs-Age(41-60Yrs) |
8.145800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.876100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.322000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.267420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.979700E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.590250E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.240200E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.524040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.140800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.106600E-01 |
| Normal-VS-Type2 PRCC |
3.880800E-01 |
| Normal-VS-KIRP CIMP |
3.281200E-03 |
| Normal-VS-Unclassified PRCC |
3.092800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.968600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.44530000000199E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.942800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.85420000004189E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
1.059750E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.119800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.064000E-01 |
| Normal-vs-N1 |
2.927900E-02 |
| Normal-vs-N2 |
7.294400E-02 |
| N0-vs-N1 |
5.237400E-03 |
| N0-vs-N2 |
1.563350E-04 |
| N1-vs-N2 |
5.740000E-02 |
|
|
